Michael Landsittel - CHIEF FINANCIAL OFFICER, Blueprint Medicines Corp

As of March 8, 2022


What is Michael Landsittel's Net Worth?

The current estimated net worth of Blueprint Medicines Corp's CHIEF FINANCIAL OFFICER, Michael Landsittel, is estimated to be about $1.36M . Michael Landsittel owns about 39,030 units of Blueprint Medicines Corp common stock. In the last 6 years at Blueprint Medicines Corp, Michael Landsittel has sold an estimated value of $290.41K worth.

What is Michael Landsittel's Past Insider Trading?

Michael Landsittel's largest sale order was 2,375 units , worth over $138.87K on March 8, 2022. In total, Michael Landsittel has made about 10 transactions over 6 years of their time at Blueprint Medicines Corp. Michael Landsittel usually trades in March, with the busiest year in 2020, 2021 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael Landsittel's Salary in 2020?

As CHIEF FINANCIAL OFFICER of Blueprint Medicines Corp, Michael Landsittel has a total base salary of $379,575 . Michael Landsittel received compensation valued at about $2,014,974 in 2020 after becoming CHIEF FINANCIAL OFFICER.

What is Michael Landsittel's' Mailing Address?

  • Mailing address is Blueprint Medicines Corp. 214 First Street, Suite 340/350 Cambridge MA 02142 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

What are Blueprint Medicines Corp's Past Insider Trades?

Blueprint Medicines Corp's most recent insider trade came on June 8, 2022 by Percy Carter who sold 1,908 units worth $114.02K . In the last 7 years, insiders at Blueprint Medicines Corp have sold an estimated value of $169.03M and bought an estimated value of $16.95M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers,  Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER,  and Kate Haviland, CHIEF OPERATING OFFICER .

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1